![]()
|
|
||||||||
J. Biol. Chem., Vol. 278, Issue 14, 12151-12156, April 4, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Pharmacology and Toxicology, College of
Pharmacy, University of Arizona, Tucson, Arizona 85721-0207
Prostaglandin E2
(PGE2) mediates its physiological effects by interactions
with a subfamily of G-protein-coupled receptors known as EP receptors.
These receptors consist of four primary subtypes named EP1,
EP2, EP3, and EP4. The
EP2 and EP4 subtypes are known to couple to
G
Prostaglandin E2 Induced Functional Expression of
Early Growth Response Factor-1 by EP4, but Not
EP2, Prostanoid Receptors via the Phosphatidylinositol
3-Kinase and Extracellular Signal-regulated Kinases*
s and stimulate intracellular cyclic 3,5- adenosine
monophosphate formation, whereas the EP1 and
EP3 receptors are known to couple to
G
q and G
i, respectively. Recently we found that EP2 and EP4 receptors can
activate T-cell factor signaling; however, EP2 receptors
did this primarily through a cAMP-dependent protein
kinase-dependent pathway, whereas EP4 receptors primarily utilized a phosphatidylinositol 3-kinase
(PI3K)-dependent pathway (Fujino, H., West, K. A., and
Regan, J. W. (2002) J. Biol. Chem. 277, 2614-2619). We now report that PGE2 stimulation of EP4 receptors, but not EP2 receptors, leads to
phosphorylation of the extracellular signal-regulated kinases (ERKs)
through a PI3K-dependent mechanism. Furthermore, this
activation of PI3K/ERK signaling by the EP4 receptors
induces the functional expression of early growth response factor-1
(EGR-1). Under the same conditions induction of EGR-1 protein
expression was not observed following PGE2 stimulation of
EP2 receptors. These findings point to important differences in the signaling potential of the EP2 and
EP4 receptors, which could be significant with respect to
the potential involvement of EP4 receptors in inflammation
and cancer.
*
This work was supported in part by Grant EY11291 from the
National Institutes of Health, Allergan Inc., and the Arizona Disease Control Research Commission.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: 520-626-2181;
Fax: 520-626-2466; E-mail: regan@pharmacy.arizona.edu.
This article has been cited by other articles:
![]() |
C. Nicola, P. K. Lala, and C. Chakraborty Prostaglandin E2-Mediated Migration of Human Trophoblast Requires RAC1 and CDC42 Biol Reprod, June 1, 2008; 78(6): 976 - 982. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-R. Pan, M.-F. Hou, H.-C. Chang, and W.-C. Hung Cyclooxygenase-2 Up-regulates CCR7 via EP2/EP4 Receptor Signaling Pathways to Enhance Lymphatic Invasion of Breast Cancer Cells J. Biol. Chem., April 25, 2008; 283(17): 11155 - 11163. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Joy and E. A. Cowley 8-iso-PGE2 Stimulates Anion Efflux from Airway Epithelial Cells via the EP4 Prostanoid Receptor Am. J. Respir. Cell Mol. Biol., February 1, 2008; 38(2): 143 - 152. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Xu, C.-L. Chou, H. Sun, H. Fujino, Q. M. Chen, and J. W. Regan FP Prostanoid Receptor-Mediated Induction of the Expression of Early Growth Response Factor-1 by Activation of a Ras/Raf/Mitogen-Activated Protein Kinase Signaling Cascade Mol. Pharmacol., January 1, 2008; 73(1): 111 - 118. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-G. Tuo, G.-R. Wen, and U. Seidler Phosphatidylinositol 3-kinase is involved in prostaglandin E2-mediated murine duodenal bicarbonate secretion Am J Physiol Gastrointest Liver Physiol, July 1, 2007; 293(1): G279 - G287. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Rao, R. Redha, I. Macias-Perez, Y. Su, C. Hao, R. Zent, M. D. Breyer, and A. Pozzi Prostaglandin E2-EP4 Receptor Promotes Endothelial Cell Migration via ERK Activation and Angiogenesis in Vivo J. Biol. Chem., June 8, 2007; 282(23): 16959 - 16968. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Hoang, A. Trinh, and R. A. Edwards Decreased MAPK- and PGE2-dependent IL-11 production in Gi{alpha}2-/- colonic myofibroblasts Am J Physiol Gastrointest Liver Physiol, June 1, 2007; 292(6): G1511 - G1519. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Sugimoto and S. Narumiya Prostaglandin E Receptors J. Biol. Chem., April 20, 2007; 282(16): 11613 - 11617. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kapoor, F. Kojima, M. Qian, L. Yang, and L. J. Crofford Microsomal Prostaglandin E Synthase-1 Deficiency Is Associated with Elevated Peroxisome Proliferator-activated Receptor {gamma}: REGULATION BY PROSTAGLANDIN E2 VIA THE PHOSPHATIDYLINOSITOL 3-KINASE AND AKT PATHWAY J. Biol. Chem., February 23, 2007; 282(8): 5356 - 5366. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hong, K. S. Ho, K. W. Eu, and P. Y. Cheah A Susceptibility Gene Set for Early Onset Colorectal Cancer That Integrates Diverse Signaling Pathways: Implication for Tumorigenesis Clin. Cancer Res., February 15, 2007; 13(4): 1107 - 1114. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Huang, S. H. Wettlaufer, C. Hogaboam, D. M. Aronoff, and M. Peters-Golden Prostaglandin E2 inhibits collagen expression and proliferation in patient-derived normal lung fibroblasts via E prostanoid 2 receptor and cAMP signaling Am J Physiol Lung Cell Mol Physiol, February 1, 2007; 292(2): L405 - L413. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.-L. Jiang, A. Nieves, W. B. Im, D. W. Old, D. T. Dinh, and L. Wheeler The Prevention of Colitis by E Prostanoid Receptor 4 Agonist through Enhancement of Epithelium Survival and Regeneration J. Pharmacol. Exp. Ther., January 1, 2007; 320(1): 22 - 28. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Frias, M. C. Rebsamen, C. Gerber-Wicht, and U. Lang Prostaglandin E2 activates Stat3 in neonatal rat ventricular cardiomyocytes: A role in cardiac hypertrophy Cardiovasc Res, January 1, 2007; 73(1): 57 - 65. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sayasith, K. A Brown, J. G Lussier, M. Dore, and J. Sirois Characterization of bovine early growth response factor-1 and its gonadotropin-dependent regulation in ovarian follicles prior to ovulation. J. Mol. Endocrinol., October 1, 2006; 37(2): 239 - 250. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Yang, Y. Huang, R. Porta, K. Yanagisawa, A. Gonzalez, E. Segi, D. H. Johnson, S. Narumiya, and D. P. Carbone Host and Direct Antitumor Effects and Profound Reduction in Tumor Metastasis with Selective EP4 Receptor Antagonism Cancer Res., October 1, 2006; 66(19): 9665 - 9672. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Cheon, Y. H. Rho, S. J. Choi, Y. H. Lee, G. G. Song, J. Sohn, N. H. Won, and J. D. Ji Prostaglandin E2 Augments IL-10 Signaling and Function J. Immunol., July 15, 2006; 177(2): 1092 - 1100. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Muller, K. J. Sales, A. A. Katz, and H. N. Jabbour Seminal Plasma Promotes the Expression of Tumorigenic and Angiogenic Genes in Cervical Adenocarcinoma Cells via the E-Series Prostanoid 4 Receptor Endocrinology, July 1, 2006; 147(7): 3356 - 3365. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Payner, H. A. Leaver, B. Knapp, I. R. Whittle, O. C. Trifan, S. Miller, and M. T. Rizzo Microsomal prostaglandin E synthase-1 regulates human glioma cell growth via prostaglandin E2-dependent activation of type II protein kinase A. Mol. Cancer Ther., July 1, 2006; 5(7): 1817 - 1826. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Alfranca, M. A. Iniguez, M. Fresno, and J. M. Redondo Prostanoid signal transduction and gene expression in the endothelium: Role in cardiovascular diseases Cardiovasc Res, June 1, 2006; 70(3): 446 - 456. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-Y. Qian, A. Leung, P. Harding, and M. C. LaPointe PGE2 stimulates human brain natriuretic peptide expression via EP4 and p42/44 MAPK Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H1740 - H1746. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Feng, E. M. Beller, S. Bagga, and J. A. Boyce Human mast cells express multiple EP receptors for prostaglandin E2 that differentially modulate activation responses Blood, April 15, 2006; 107(8): 3243 - 3250. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yamaguchi, S.-H. Lee, J.-S. Kim, J. Wimalasena, S. Kitajima, and S. J. Baek Activating Transcription Factor 3 and Early Growth Response 1 Are the Novel Targets of LY294002 in a Phosphatidylinositol 3-Kinase-Independent Pathway Cancer Res., February 15, 2006; 66(4): 2376 - 2384. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Pavlovic, B. Du, K. Sakamoto, K. M. F. Khan, C. Natarajan, R. M. Breyer, A. J. Dannenberg, and D. J. Falcone Targeting Prostaglandin E2 Receptors as an Alternative Strategy to Block Cyclooxygenase-2-dependent Extracellular Matrix-induced Matrix Metalloproteinase-9 Expression by Macrophages J. Biol. Chem., February 10, 2006; 281(6): 3321 - 3328. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. I. Cha, S.-H. Kim, D. Sepich, F. G. Buchanan, L. Solnica-Krezel, and R. N. DuBois Cyclooxygenase-1-derived PGE2 promotes cell motility via the G-protein-coupled EP4 receptor during vertebrate gastrulation Genes & Dev., January 1, 2006; 20(1): 77 - 86. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Fujino and J. W. Regan EP4 Prostanoid Receptor Coupling to a Pertussis Toxin-Sensitive Inhibitory G Protein Mol. Pharmacol., January 1, 2006; 69(1): 5 - 10. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. G. Friis, J. Stubbe, T. R. Uhrenholt, P. Svenningsen, R. M. Nusing, O. Skott, and B. L. Jensen Prostaglandin E2 EP2 and EP4 receptor activation mediates cAMP-dependent hyperpolarization and exocytosis of renin in juxtaglomerular cells Am J Physiol Renal Physiol, November 1, 2005; 289(5): F989 - F997. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C. Rodriguez, C. P. Hernandez, D. Quiceno, S. M. Dubinett, J. Zabaleta, J. B. Ochoa, J. Gilbert, and A. C. Ochoa Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma J. Exp. Med., October 3, 2005; 202(7): 931 - 939. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Milne, T. A. Henderson, R. W. Kelly, P. T. Saunders, D. T. Baird, and H. O. D. Critchley Leukocyte Populations and Steroid Receptor Expression in Human First-Trimester Decidua; Regulation by Antiprogestin and Prostaglandin E Analog J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4315 - 4321. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Fujino, S. Salvi, and J. W. Regan Differential Regulation of Phosphorylation of the cAMP Response Element-Binding Protein after Activation of EP2 and EP4 Prostanoid Receptors by Prostaglandin E2 Mol. Pharmacol., July 1, 2005; 68(1): 251 - 259. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y Kamei, Y Aoyama, T Fujimoto, N Kenmotsu, C Kishi, M Koushi, S Sugano, K Morohashi, R Kamiyama, and R Asakai A steroidogenic cell line with differentiation potential from mouse granulosa cells, transfected with Ad4BP and SV40 large T antigen genes J. Endocrinol., April 1, 2005; 185(1): 187 - 195. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. H. Faour, N. Alaaeddine, A. Mancini, Q. W. He, D. Jovanovic, and J. A. Di Battista Early Growth Response Factor-1 Mediates Prostaglandin E2-dependent Transcriptional Suppression of Cytokine-induced Tumor Necrosis Factor-{alpha} Gene Expression in Human Macrophages and Rheumatoid Arthritis-affected Synovial Fibroblasts J. Biol. Chem., March 11, 2005; 280(10): 9536 - 9546. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Comer, C. L. Galindo, A. K. Chopra, and J. W. Peterson GeneChip Analyses of Global Transcriptional Responses of Murine Macrophages to the Lethal Toxin of Bacillus anthracis Infect. Immun., March 1, 2005; 73(3): 1879 - 1885. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Chen and N. G. Bazan Endogenous PGE2 Regulates Membrane Excitability and Synaptic Transmission in Hippocampal CA1 Pyramidal Neurons J Neurophysiol, February 1, 2005; 93(2): 929 - 941. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Clarke, M. G. Belvisi, S. J. Smith, E. Hardaker, M. H. Yacoub, K. K. Meja, R. Newton, D. M. Slater, and M. A. Giembycz Prostanoid receptor expression by human airway smooth muscle cells and regulation of the secretion of granulocyte colony-stimulating factor Am J Physiol Lung Cell Mol Physiol, February 1, 2005; 288(2): L238 - L250. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Spinella, L. Rosano, V. Di Castro, P. G. Natali, and A. Bagnato Endothelin-1-induced Prostaglandin E2-EP2, EP4 Signaling Regulates Vascular Endothelial Growth Factor Production and Ovarian Carcinoma Cell Invasion J. Biol. Chem., November 5, 2004; 279(45): 46700 - 46705. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Hull, S. C.W. Ko, and G. Hawcroft Prostaglandin EP receptors: Targets for treatment and prevention of colorectal cancer? Mol. Cancer Ther., August 1, 2004; 3(8): 1031 - 1039. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Pozzi, X. Yan, I. Macias-Perez, S. Wei, A. N. Hata, R. M. Breyer, J. D. Morrow, and J. H. Capdevila Colon Carcinoma Cell Growth Is Associated with Prostaglandin E2/EP4 Receptor-evoked ERK Activation J. Biol. Chem., July 9, 2004; 279(28): 29797 - 29804. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Akaogi, H. Yamada, Y. Kuroda, D. C. Nacionales, W. H. Reeves, and M. Satoh Prostaglandin E2 receptors EP2 and EP4 are up-regulated in peritoneal macrophages and joints of pristane-treated mice and modulate TNF-{alpha} and IL-6 production J. Leukoc. Biol., July 1, 2004; 76(1): 227 - 236. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Sales, S. Maudsley, and H. N. Jabbour Elevated Prostaglandin EP2 Receptor in Endometrial Adenocarcinoma Cells Promotes Vascular Endothelial Growth Factor Expression via Cyclic 3',5'-Adenosine Monophosphate-Mediated Transactivation of the Epidermal Growth Factor Receptor and Extracellular Signal-Regulated Kinase 1/2 Signaling Pathways Mol. Endocrinol., June 1, 2004; 18(6): 1533 - 1545. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-Y. Xiao, K.-i. Yuhki, A. Hara, T. Fujino, S. Kuriyama, T. Yamada, K. Takayama, O. Takahata, H. Karibe, T. Taniguchi, et al. Prostaglandin E2 Protects the Heart From Ischemia-Reperfusion Injury via Its Receptor Subtype EP4 Circulation, May 25, 2004; 109(20): 2462 - 2468. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.-c. Li, T. Cindrova-Davies, J. N. Skepper, and L. A. Sellers Prostacyclin Induces Apoptosis of Vascular Smooth Muscle Cells by a cAMP-Mediated Inhibition of Extracellular Signal-Regulated Kinase Activity and Can Counteract the Mitogenic Activity of Endothelin-1 or Basic Fibroblast Growth Factor Circ. Res., April 2, 2004; 94(6): 759 - 767. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Subbaramaiah, K. Yoshimatsu, E. Scherl, K. M. Das, K. D. Glazier, D. Golijanin, R. A. Soslow, T. Tanabe, H. Naraba, and A. J. Dannenberg Microsomal Prostaglandin E Synthase-1 Is Overexpressed in Inflammatory Bowel Disease: EVIDENCE FOR INVOLVEMENT OF THE TRANSCRIPTION FACTOR Egr-1 J. Biol. Chem., March 26, 2004; 279(13): 12647 - 12658. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Katz, C. Lord, C. A. Ford, S. B. Gauld, N. A. Carter, and M. M. Harnett Bcl-xL antagonism of BCR-coupled mitochondrial phospholipase A2 signaling correlates with protection from apoptosis in WEHI-231 B cells Blood, January 1, 2004; 103(1): 168 - 176. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |